Provexis, announced the resignation of Frédéric Boned, a Non-executive Director of the Company, with immediate effect. Frédéric Boned joined the Board of Provexis as a Non-executive Director in July 2018, at which point he was EMEA Vice President of DSM's Human Nutrition & Health business, a part of DSM Nutritional Products. Frédéric, who is currently Regional Vice President Health Nutrition & Care North America at DSM, has announced his resignation from DSM with effect from 15 October 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 GBX | 0.00% |
|
0.00% | -7.69% |
04-03 | Quiz sales fall, names new CEO; Byotrol eyes AIM exit | AN |
2023 | Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-7.69% | 17.17M | |
+13.21% | 8.1B | |
+4.64% | 7.57B | |
-17.32% | 5B | |
-8.76% | 3.57B | |
-20.43% | 3.2B | |
-11.51% | 1.19B | |
-31.91% | 1.06B | |
-15.60% | 867M | |
-8.57% | 861M |
- Stock Market
- Equities
- PXS Stock
- News Provexis plc
- Provexis plc Announces Directorate Change